Home / Stocks / CIM

Chimera Investment (CIM, Mortgage REITs) Stock Valuation & Fair Value Fairly valued

Chimera Investment (CIM, Mortgage REITs) trades at a blended P/E of 5.9, about 22% below its historical normal valuation, with a forward growth estimate of 1.3% and a PEG of 4.50. Analysts' one-year estimates have been hit 45% of the time. Priced at its historical normal P/E of 7.6 on the same blended earnings, the 2026-09-18 close of $10.87 corresponds to about $14.00 a share. This is a valuation reference, not a price target.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.

DATA AS OF 2026-09-21
Blended P/E
5.9
Normal P/E
7.6
PEG
4.50
Fwd growth
1.3%
Div yield
16.6%
RSI (14)
41.4
Neutral

The Street vs SeerForecast

Wall Street's mean price target for CIM is $14.17 across 3 analysts, 31.8% above the current price. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-07-31.

Blended P/E and rating by weekBlended P/E moved from 6.5 to 5.9 between 2026-07-31 and 2026-09-21, against a normal P/E of 7.6, with 0 rating changes over 18 recorded weeks.2026-07-31: P/E 6.5, Fairly valued (recalculated)2026-08-03: P/E 6.4, Fairly valued2026-08-07: P/E 6.4, Fairly valued (recalculated)2026-08-10: P/E 6.2, Fairly valued2026-08-14: P/E 6.2, Fairly valued (recalculated)2026-08-17: P/E 6.1, Fairly valued2026-08-21: P/E 6.1, Fairly valued (recalculated)2026-08-24: P/E 6.2, Fairly valued2026-08-27: P/E 6.2, Fairly valued (recalculated)2026-08-28: P/E 6.2, Fairly valued (recalculated)2026-08-30: P/E 6.2, Fairly valued (recalculated)2026-08-31: P/E 6.2, Fairly valued2026-09-05: P/E 6.2, Fairly valued (recalculated)2026-09-07: P/E 6.3, Fairly valued2026-09-12: P/E 6.3, Fairly valued (recalculated)2026-09-14: P/E 6.0, Fairly valued2026-09-19: P/E 6.0, Fairly valued (recalculated)2026-09-21: P/E 5.9, Fairly valued6.06.57.07.5Jul 31Aug 13Aug 26Sep 8Sep 21Normal P/E 7.6
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-07-31P/E 6.5-14%Fairly valued
2026-09-21P/E 5.9-22%Fairly valued ← now

Frequently asked questions

Is Chimera Investment stock overvalued?

At a blended P/E of 5.9 versus its historical normal P/E of 7.6, Chimera Investment trades about 22% below its typical valuation, with a PEG of 4.50 on 1.3% forward growth. tickerseer currently rates it fairly valued.

What is Chimera Investment's fair value and PEG?

Chimera Investment trades at a blended P/E of 5.9 against a historical normal P/E of 7.6, a PEG of 4.50, and a forward growth estimate of 1.3%. Priced at its historical normal P/E of 7.6 on the same blended earnings, the 2026-09-18 close of $10.87 corresponds to about $14.00 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Chimera Investment changed?

tickerseer's rating has been fairly valued since 2026-07-31.

What is the analyst price target for Chimera Investment?

The mean Wall Street price target for Chimera Investment is $14.17 across 3 analysts, 31.8% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Mortgage REITs. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track CIM free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.